Association of Dexmedetomidine With New-Onset Atrial Fibrillation in Patients With Critical Illness.

ABSTRACT:

Importance

Dexmedetomidine is a widely used sedative in the intensive care unit (ICU) and has unique properties that may be associated with reduced occurrence of new-onset atrial fibrillation (NOAF).

Objective

To investigate whether the use of dexmedetomidine is associated with the incidence of NOAF in patients with critical illness.

Design, setting, and participants

This propensity score-matched cohort study was conducted using the Medical Information Mart for Intensive Care-IV database, which includes records of patients admitted to the ICU at Beth Israel Deaconess Medical Center in Boston dating 2008 through 2019. Included patients were those aged 18 years or older and hospitalized in the ICU. Data were analyzed from March through May 2022.

Exposure

Patients

SUBMITTER: Song MJ 

PROVIDER: S-EPMC10130948 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature